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     Several DNA damage checkpoint factors form nuclear foci in response to ionizing 
radiation (IR). Although the number of the initial foci decreases concomitantly with 
DNA double-strand break repair, some fraction of foci persists. To date, the 
physiological role of the persistent foci has been poorly understood. Here we examined 
foci of Ser1981-phosphorylated ATM in normal human diploid cells exposed to 1 Gy of 
X-rays. While the initial foci size was approximately 0.6 µm, the one or two of 
persistent focus (foci) grew, whose diameter reached 1.6 µm or more in diameter at 24 h 
after IR. All of the grown persistent foci of phosphorylated ATM colocalized with the 
persistent foci of Ser139-phosphorylated histone H2AX, MDC1, 53BP1 and NBS1, 
which also grew similarly. When G0-synchronized normal human cells were released 
immediately after 1 Gy of X-rays and incubated for 24 h, the grown large 
phosphorylated ATM foci (≥1.6 µm) were rarely (av. 0.9%) observed in S phase cells, 
while smaller foci (<1.6 µm) were frequently (av. 45.9%) found. We observed 
significant phosphorylation of p53 at Ser15 in cells with a single grown phosphorylated 
ATM focus. Furthermore, persistent inhibition of foci growth of phosphorylated ATM 
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by an ATM inhibitor, KU55933, completely abrogated p53 phosphorylation. Defective 
growth of the persistent IR-induced foci was observed in primary fibroblasts derived 
from ataxia-telangiectasia (AT) and Nijmegen breakage syndrome (NBS) patients, 
which were abnormal in IR-induced G1 checkpoint.           
     These results indicate that the growth of the persistent foci of the DNA damage 
checkpoint factors plays a pivotal role in G1 arrest, which amplifies G1 checkpoint 













     Human cells have evolved highly sophisticated mechanisms of cell cycle 
checkpoint to counteract DNA damage caused by various environmental stresses, such 
as ionizing radiation (IR). The central player in cell cycle checkpoint is ATM protein 
kinase, which is a responsible gene product for cancer-predisposed disease, 
ataxia-telangiectasia (AT) [1]. Cells derived from AT patients show higher 
radiosensitivity, and have defects in DNA double-strand break (DSB) repair and 
IR-induced cell cycle checkpoints [2-5]. ATM belongs to phosphatidylinositol 3-kinase 
family, and it phosphorylates many checkpoint-, or repair-related proteins, including 
p53 (Ser15), CHK2/hCds1 (Thr68), and NBS1 (Ser278, and 343) [6-12]. Bakkenist and 
Kastan reported that ATM forms dimer or high-order multimer in unperturbed cells, and 
in response to IR, it is activated through intermolecular autophosphorylation at its 
Ser1981 and dimer dissociation [13]. Interestingly, these phosphorylated ATM 
molecules concentrate at specific sites in the nucleus after IR, which are visualized as 
“foci” by immunofluorescence staining [13]. One of the ATM substrates is histone 
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H2AX, which belongs to the core histone H2A subfamily [14, 15]. H2AX is 
phosphorylated by ATM at its C-terminal Ser139 in response to IR [15]. The 
phosphorylated H2AX also forms discrete foci in the nucleus after IR, and the foci 
colocalize with phosphorylated ATM foci [13, 16, 17]. The number of phosphorylated 
H2AX foci is well consistent with the theoretically calculated number of DSBs 
produced by IR, and the foci number decreases gradually after irradiation, reflecting 
DSB repair [16, 17]. Recent studies demonstrated that several other proteins also form 
foci in the nucleus after IR. For example, 53BP1, which was originally isolated as a 
p53-binding protein, forms foci in the nucleus after IR, and the 53BP1 foci colocalize 
with phosphorylated H2AX foci [18-20]. MDC1, which was isolated as a factor 
associated with MRE11-Rad50-NBS1 complex, also forms foci colocalized with 
phosphorylated H2AX foci after IR [21].  
     There is accumulating evidence that these focus-forming factors are involved in 
IR-induced checkpoint. Fernandez-Capetillo et al. reported that G2/M checkpoint is 
impaired in H2AX-, or 53BP1 knockout mouse after low doses (≤2 Gy) of IR [22]. It 
was also reported that radioresistant DNA synthesis (RDS) phenotype, which suggests 
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aberration of IR-induced S checkpoint, is observed in 53BP1-siRNA-expressing cells 
[23]. MDC1-knocked-down cells also show partial defect in S-, or G2/M checkpoint 
after IR [24, 25]. Substrate phosphorylation by ATM seems to occur at damaged site, 
because Lukas et al. demonstrated that Thr68 phosphorylation of CHK2-hCds1 occurs 
only at laser-microirradiated site, using ectopically-expressed CHK2 protein 
immobilized by fusion with histone H2B [26]. These results suggest that foci of 
phosphorylated H2AX, 53BP1, and MDC1 serve as molecular scaffolds of substrate 
phosphorylation by ATM.  
     As mentioned above, relationship between the initially-formed IR-induced foci 
and checkpoint activation has been intensively studied. However, the initial foci number 
decreases concurrently with DNA repair, and only a few foci persist for over 24 h, 
particularly with low doses of IR, such as 1 Gy. Because G1 checkpoint activation is 
slowly elicited, most of the initial foci disappear while G1 arrest persists. Thus, cells 
with a limited number of persistent foci should have a mechanism to amplify G1 
checkpoint signals. Because the standard technique, such as western blotting, fails to 
detect changes in foci, we examined the role of the persistent foci of phosphorylated 
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ATM in individual cells by immunofluorescence staining. We found the persistent foci 
grew in size, and the foci growth is essential for G1 arrest. We propose that it is the 
persistent phosphorylated ATM foci, not the initial foci, that determine whether cells are 
arrested at G1/S border, and the growth of the persistent foci is the indispensable 
mechanism for amplification of G1 checkpoint signaling in cells with a limited number 












2. Materials and methods 
 
2.1. Cell culture and irradiation 
      
     Normal human diploid cells (HE49), primary fibroblasts derived from patients 
with ataxia telangiectasia (AT2KY and AT5BI) and Nijmegen breakage syndrome 
(WG1799) were cultured in minimal essential Eagle’s media (MEM) containing 10% 
fetal bovine serum (ThermoTrace Ltd., Australia). Five to ten x 104 cells were seeded 
onto 22 mm x 22 mm coverslips in 35 mm dishes. Two days later, cells were irradiated 
with X-rays from X-ray generator at 150 kVp and 5 mA with a 0.1 mm copper filter at a 
dose rate of 0.492 Gy/min. Nutlin-3 (Alexis biochemicals, USA) was dissolved in 
DMSO to prepare 8 mM stock solution, and was treated at a final concentration of 8, or 
32 µM. KU55933 was dissolved in DMSO to prepare 20 mM stock solution, and was 
treated at a final concentration of 10 µM.  
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2.2. Synchronization of cell cycle 
 
     G0 synchronization was achieved by contact inhibition. One x 106 of HE49 cells 
or WG1799 cells were plated in T25 flasks (25 cm2) and cultured 14 days (HE49) or 28 
days (WG1799), with changing the culture media every 3 or 4 days. Under these 
conditions, less than 2% of cells showed staining of replication protein A and 
Ser10-phosphorylated histone H3, which indicate S phase cells and G2/M phase cells, 
respectively. At day 15 or 29, cells were irradiated, harvested with trypsin immediately 
after IR, and 1 x105 cells were replated onto 22 x 22 mm coverslips in 35 mm dishes to 
release from synchronization. Thereafter, cells were fixed followed by 
immunofluorescence staining.  
 
2.3. Immunofluorescence staining 
 
     For immunofluorescence staining, cells were once washed with 1 x PBS-, and 
were fixed with 4% formaldehyde in 1 x PBS- for 10 min, then permeabilized with 0.5% 
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Triton X-100 in 1 x PBS- for 5 min. For RPA staining, cells were once washed with 
CSK buffer (10 mM HEPES-KOH, pH 7.4, 300 mM Sucrose, 100 mM NaCl, 3 mM 
MgCl2・6H2O), then extracted with 0.5% Triton X-100 in 1 x PBS
-  for 2 min. After 
extraction, cells were fixed with 4% formaldehyde in 1 x PBS- for 20 min, and then, 
permeabilized with 0.5% Nonidet P-40 in 1 x PBS- for 5 min. For bromodeoxyuridine 
(BrdU) staining, G0-synchronized HE49 cells were treated with 0.5 mM BrdU/0.05 mM 
fluorodeoxyuridine (FldU) immediately after release from synchronization, and cells 
were incubated in the media containing BrdU/FldU until fixation. Twenty-four hours 
after release, cells were once washed by 1 x PBS-, then fixed with 100% methanol for 5 
min. After fixation, cells were treated with 1 N HCl for 30 min, to hydrolyze DNA. All 
reagents were chilled, and all procedures were performed on ice. After permeabilization, 
primary antibody for phosphorylated ATM at Ser1981 (mouse; Rockland, USA, clone 
10H11.E12, rabbit; Rockland, USA), phosphorylated histone H2AX at Ser139 (mouse; 
Upstate, USA, clone JBW301), MDC1 (rabbit; Bethyl, USA), 53BP1 (mouse; 
Calbiochem, USA, clone BP13, rabbit; Bethyl, USA), NBS1 (mouse; Genetex, USA, 
clone 1D7), 34 kDa subunit of replication protein A (RPA, mouse; Calbiochem, USA, 
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clone RPA34-19), BrdU (mouse; Roche Applied Science, Switzerland, clone 
BMC9318), phosphorylated histone H3 at Ser10 (mouse; Upstate, USA, clone RR002, 
rabbit; Upstate, USA), or phosphorylated p53 at Ser15 (rabbit; Cell Signaling 
Technology, USA) was treated for 2 h in a 37˚C humidified CO2 incubator. After 
washing with 1 x PBS- for 3 times, secondary antibody conjugated with Alexa 488 or 
594 (Molecular Probes, USA) was treated for 1 h in the incubator. All antibodies were 
dissolved in TBS-DT (20mM Tris-HCl, 137mM NaCl, 0.1% Tween 20, 125µg/ml 
ampicillin, 5% skim milk). After washing with 1 x PBS- for 3 times, coverslips were 
mounted onto slide glasses with 10% Glycerol in 1 x PBS-. The digital images of the 
primary antibodies were acquired using fluorescence microscopy (DM6000B, Leica, 
Germany). Foci analysis was performed by using maximum intensity projection (MIP) 
images. The Z-plane stacks of images of foci were captured at 200-300 nm intervals, 
and 10-20 images at each focal plane were collected. Then, regions at maximum 
intensity at each focal plane were assembled into a 2D MIP image using FW4000 
software (Leica, Germany). Focus diameter was measured using FW4000, by encircling 
the focus in the captured image. In the present study, we described the major axis of the 
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focus as “diameter”, because the focus of the proteins is not a bona fide circle. 
Fluorescence intensity of phosphorylated ATM and phosphorylated p53 was measured 
by the following procedure: the nucleus stained by DAPI was encircled and 
fluorescence intensity in the encircled area was measured. The area outside the nucleus 
was also encircled and fluorescence intensity in the area was measured to obtain 
background intensity. The intensity outside the nucleus was subtracted from the 
intensity in the nucleus to obtain actual nuclear intensity of the proteins.  












3.1. Growth of persistent IR-induced foci in normal human diploid cells 
 
     To know the dynamics of IR-induced foci, we first performed spatiotemporal 
analysis of Ser1981-phosphorylated ATM foci after 1 Gy of X-rays in normal human 
diploid cells (Fig. 1). While most of the unirradiated cells had no phosphorylated ATM 
foci, many tiny foci of phosphorylated ATM were detected immediately after IR. The 
initial foci number peaked at 15 min (av. 36.9 per nucleus), and decreased subsequently, 
reflecting DSB repair (Fig. 1A).  
     As shown in Fig. 1A, some foci persisted and we found that some of the cells had 
larger foci (>1 µm in diameter) from 4 h after IR, compared to initial foci observed 
within 30 min (≤0.5 µm, Fig. 1B). Some of the persistent foci seemed to grow 
time-dependently up to 24 h after IR (Fig. 1B). Therefore, we measured diameter of 
each phosphorylated ATM focus at each time point (Fig. 1C). In unirradiated cells, 
9.5 % of cells were foci-positive, however, large foci (≥1.6 µm) were frequently found 
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in the foci-positive cells, (Table 1 and Fig. 1C, control). At 1-2 h after IR, 100% of cells 
became foci positive. At these time points, many small foci, most of which diameter 
distributed between 0.4 to 1 µm, were observed in every interphase nucleus, and almost 
no large foci as was observed in the control cells were found (Table 1). Distribution of 
bars in histograms shift to right between 4 and 24 h after IR, indicating that diameter of 
the persistent foci increased time-dependently after IR, and thereafter, it does not 
change significantly (cf. Fig. 1C, 24 h and Fig. 1G, 1 Gy 48 h). We confirmed similar 
growth of the persistent phosphorylated ATM foci after IR in widely-used human 
primary fibroblasts, such as BJ, MRC-5, and WI38 (data not shown). The foci growth 
long after IR was also observed in persistent foci of Ser139-phosphorylated histone 
H2AX, MDC1, 53BP1, and NBS1 (Fig. 1D), and the grown foci of these proteins 
colocalized perfectly with the grown foci of phosphorylated ATM (Fig. 1D).  
     Next we examined dose-dependency of the growth of the persistent 
phosphorylated ATM foci in G0-irradiated normal human diploid cells. Percentage of 
cells with the large foci (≥1.6 µm) increased in a dose-dependent manner, and the 
average number of the large foci per cell also increased dose-dependently 48 h after IR 
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(Fig. 1E and 1F). However, we observed no significant difference in foci size 
distribution 48 h after 1-8 Gy (Fig. 1G). 
 
3.2. Role of the growth of the persistent foci in IR-induced G1 arrest 
      
     To know whether the grown persistent foci inhibit G1/S progression, 
G0-synchronized normal human diploid cells were irradiated with 1 Gy of X-rays, then, 
cells were released from synchronization immediately after IR, by trypsinizing and 
replating cells at low density. Twenty-four hours after release, cells were fixed and 
subjected to immunofluorescence staining for phosphorylated ATM and replication 
protein A (RPA) (Fig. 2A). In this experimental setting, RPA-positive S-phase cells 
appeared from 24 h after release irrespective of irradiation. Twenty-four hours after 
release, av. 39% of unirradiated cells, and av. 25% of 1 Gy-irradiated cells became 
RPA-positive, respectively (Fig. 2A). In this analysis, we categorized phosphorylated 
ATM foci into two groups: small foci (<1.6 µm) and large foci (≥1.6 µm), because focus 
size has variety. In 1 Gy-irradiated RPA positive cells, the large foci of phosphorylated 
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ATM were rarely (0.9%) found, while the small foci were observed in 45.9% of the cells 
(Fig. 2A, right bar). Next, in Figure 2B, percentage of RPA positive cells with no foci 
was set for 100%, and relative percentage of RPA positive cells with the small foci or 
the large foci was shown, to make the effect of foci growth on S phase entry clearer. 
Compared to cells with no foci, much lower percentage (1.8%) of the large foci positive 
cells had RPA staining, while only slightly-decreased percentage (79%) of cells with the 
small foci were RPA positive (Fig. 2B). We performed the same assay by continuous 
BrdU-labeling, and confirmed that very few cells (0.9 %) with the large foci were 
labeled with BrdU (Fig. 2C). These results indicate that most of the cells with the large 
foci stayed in G1 phase, and did not progress into S, or G2/M phase because BrdU was 
continuously treated from immediately after synchronization release to the time of 
fixation. To further substantiate RPA/BrdU negative cells with the large foci stay in G1 
phase, G2/M cells were identified by the signal of phosphorylated histone H3 at Ser10. 
Percentage of individual cell cycle phases were given in Table 2. Cells positive for RPA 
staining were judged as S phase cells. G2/M cells were positive for phosphorylated 
histone H3 at Ser10. And both RPA and phosphorylated histone H3 negative cells were 
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regarded as G1 phase cells. Percentages of S phase cells with the large foci were almost 
the same between control and 1 Gy-irradiated cells (0.1% and 0.2%, respectively), 
whereas the fraction of cells with the large foci was significantly increased in irradiated 
G1 cells, compared to that in control G1 cells. None of the large foci positive cells were 
observed in both control and irradiated G2/M cells. In contrast, S phase cells with the 
small foci increased by irradiation (6.9% to 10.6%), though total S phase cells 
decreased after irradiation (39.4% to 24.7%). G2/M cells with the small foci were rarely 
observed both in control and irradiated cells (1.6% and 1.3%, respectively).   
 
3.3. Correlation between the growth of phosphorylated ATM foci and the level of p53 
phosphorylation 
      
     To determine whether the growth of the persistent foci is involved in 
amplification of G1 checkpoint signals, we examined the relationship between 
phosphorylated ATM foci and Ser15-phosphorylation of p53 (Fig. 3). It is well 
documented that the level of p53 protein after IR shows oscillation caused by 
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MDM2-mediated autoregulatory feedback loop [27, 28]. Therefore, it is possible that 
we underestimate the effect of the foci growth on p53 phosphorylation due to low levels 
of p53 as a result of oscillation. To rule out the possibility, we used Nutlin-3, which 
stabilizes p53 through inhibition of p53-MDM2 binding, to make p53 levels constant in 
all cells (Fig. 3A) [29]. Furthermore, we used G0-synchronized cells to exclude the 
possibility of p53 phosphorylation by ATR in S phase. Intriguingly, we observed more 
p53 phosphorylation in cells with grown foci than in cells with small or no foci (Fig. 3B, 
HE49). We analyzed correlation between fluorescence intensity of nucleoplasmic 
phosphorylated p53 and fluorescence intensity of nucleoplasmic phosphorylated ATM, 
which represents the sum of each focus’s fluorescence (Fig. 3C, HE49). On the whole, 
fluorescence intensity of phosphorylated ATM decreased time-dependently after IR, 
because the loss of fluorescence by foci disappearance surpassed the gain of 
fluorescence by growth of the persistent foci (Fig. 3C, HE49). Concomitantly, 
fluorescence intensity of phosphorylated p53 decreased time-dependently overall. 
However, in normal cells, some of the cells maintained strong fluorescence intensity of 
phosphorylated ATM and phosphorylated p53 until 24 h after 1 Gy, like cells at 2 h after 
 20
1 Gy, or 24 h after 6 Gy, though most of the initial phosphorylated ATM foci 
disappeared at this time. All of such cells had the large phosphorylated ATM foci (≥1.6 
µm) (Fig. 3B, HE49, 24 h after IR). We also performed the same assay using primary 
fibroblasts derived from a Nijmegen breakage syndrome (NBS) patient, because it is 
previously reported that NBS cells have a partial defect in ATM autophosphorylation at 
Ser1981, p53 phosphorylation at Ser15, and G1 arrest (Fig. 3B and 3C, WG1799) 
[30-32]. In NBS cells, growth of the persistent phosphorylated ATM foci seemed to be 
impaired (Fig. 3B, WG1799). Concomitantly with the defective foci growth, intensity of 
both phosphorylated ATM and phosphorylated p53 in NBS cells was lower than that in 
normal cells throughout the time course, and almost no NBS cells maintained strong 
intensity of both proteins 24 h after 1 Gy (Fig. 3C, WG1799). Although we also 
observed lower induction of p53 phosphorylation in NBS cells by western blotting at 2, 
and 4 h after IR, the difference of p53 phosphorylation in normal and NBS cells at 8, 
and 24 h after IR could not be detected by this analysis, suggesting the importance of 
individual cell analysis in Fig. 3C (Fig. 3D and 3E). Next we investigated 
p53-phosphorylating ability of a single phosphorylated ATM focus at 24 h after 1 Gy of 
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X-rays in normal cells. We observed clear correlation between diameter of a single 
phosphorylated ATM focus and fluorescence intensity of nucleoplasmic phosphorylated 
p53 (Fig. 3F).  
 
3.4. Defective growth of the persistent IR-induced foci in AT-, and NBS cells 
 
     Previous studies demonstrated that cells derived from AT-, or NBS patients show 
multiple cell cycle checkpoint defects, including G1 checkpoint [3, 4, 31-33]. And 
furthermore, ATM and NBS1, which are responsible gene products for the diseases, are 
the components of the persistent grown IR-induced foci as described above (Fig. 1D). 
Therefore, we next analyzed 53BP1 foci in AT (AT2KY and AT5BI) and NBS primary 
fibroblasts after 1 Gy of X-rays (Fig. 4). When unirradiated, larger percentage of these 
cells were positive for 53BP1 foci compared to normal human cells (AT2KY; 19%, 
AT5BI; 46%, WG1799; 33%, cf. HE49; 9.5%, data not shown), and average number of 
53BP1 foci per nucleus in these unirradiated cells were more than that in normal cells 
(AT2KY; 0.22, AT5BI; 0.73, WG1799; 0.43, Fig. 4B. cf. HE49; 0.15). However, size of 
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53BP1 foci observed in unirradiated AT-, or NBS cells was smaller than those of normal 
cells (Fig. 4C, control). Furthermore, maximal number of 53BP1 foci per nucleus in 1 
Gy-irradiated AT-, or NBS cells was less than that in normal cells (cf. 36.9 at 15 min 
after IR in HE49, 27.7 at 15 min after IR in AT2KY, 26.8 at 30 min after IR in AT5BI, 
and 19.7 at 1 h after IR in WG1799, Fig. 4A). Although foci size distribution was not 
significantly different between AT, NBS, and normal cells at 1-2 h after IR, growth of 
persistent foci from 4 h was less pronounced in AT and NBS cells. Defective growth of 
the persistent foci was most clearly observed 24 h after IR (Fig. 4C, 24 h and 4D). We 
next examined the relationship between focus size of phosphorylated ATM and S phase 
entry in NBS primary fibroblasts and normal human diploid cells (Table 3). 
G0-synchronized WG1799 and HE49 cells were irradiated or unirradiated with 1 Gy of 
X-rays, and immediately released from synchronization. Twenty-four hours after release, 
cells were fixed and immunostained with phosphorylated ATM and RPA. In unirradiated 
RPA positive NBS cells, 37.1% of cells were foci positive, and all foci in these cells 
were the small foci. We did not observe a large focus in unirradiated RPA positive NBS 
cells. Although 1 Gy of X-rays increased the percentage of RPA positive cells with foci 
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(83.6%), all foci in the irradiated RPA positive NBS cells were the small foci, and no 
large foci were detected. In RPA negative NBS cells, only few large foci were observed 
in both control and 1 Gy-irradiated cells (1.4% and 1.3%, respectively), confirming that 
growth of the persistent phosphorylated ATM foci is impaired in NBS cells. This is in 
contrast to 21.6% of 1 Gy-irradiated RPA negative normal cells that had the large 
phosphorylated ATM foci.      
 
3.5. Functional distinction between the large foci and the small foci 
      
     To determine functional distinction between the large foci and the small foci, we 
performed chemical intervention of the foci growth in the time interval after the 
appearance of the small foci but before the growth to the large foci (Fig. 5). To achieve 
this, we used KU55933 (KU), an established inhibitor of ATM kinase activity (Fig. 5A) 
[34]. KU was treated from 4 h after 1 Gy of X-rays, at which time, the growth of the 
persistent foci begins (Fig.1B and C). We analyzed foci of phosphorylated ATM 24 h 
after 1 Gy in normal human diploid cells, and found that the foci growth was 
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significantly inhibited by the KU treatment from 4 h to 24 h after IR (Fig. 5B and C). 
Importantly, the small phosphorylated ATM foci, whose diameter was 0.5  0.2 µm, still 
remained (Fig. 5C). We also examined whether p53 was phosphorylated in cells with 
the persistent small phosphorylated ATM foci (Fig. 5D and E). Without KU treatment, 
significant nuclear fluorescence of Ser15-phosphorylated p53 was found specifically in 
cells with the large phosphorylated ATM (Fig. 5E, indicated by white arrows in left 
panel). In contrast, with the KU treatment, no apparent phosphorylation of p53 was 











      
     Results in the present study strongly indicate that the persistent foci of checkpoint 
factors remaining long after IR should be distinguished from the initial foci formed 
immediately after IR, when considering G1 checkpoint activation. Previously, Pilch et al. 
described the growth of the initial foci of phosphorylated histone H2AX within 90 min 
after IR [35]. In our observation, not only the initial foci of phosphorylated H2AX, but 
also those of phosphorylated ATM and 53BP1 grew (data not shown). The foci growth 
we described in the present study follows the initial foci growth, however, importantly, 
the “later” growth occurs only in the persistent foci long time after IR. If the initial foci 
determined the cell fate, all cells would undergo G1 arrest even after very low doses of 
IR, because the initial foci appear and grow in all interphase cells irradiated (Table 1, 
and data not shown). However, G1 checkpoint is characterized by its slower activation 
and persistence, which are major differences from S, or G2/M checkpoint [36, 37]. 
Therefore, most of the initial foci disappear at the onset of G1 arrest (Fig. 1A). 
Inevitably, cells with a limited number of irreparable damage must possess a mechanism 
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to amplify G1 checkpoint signals. In fact, we found growth of the persistent IR-induced 
foci in normal human diploid cells. This observation led us to speculate that, even with 
a single persistent focus, DNA damage signal can be amplified sufficiently for G1 arrest 
by the growth of the persistent focus. As expected, G1 cells with grown phosphorylated 
ATM foci showed difficulty to progress into S phase (Fig. 2, Table 2 and 3). We 
confirmed significant correlation between diameter of a single persistent 
Ser1981-phosphorylated ATM focus and fluorescence intensity of Ser15-phosphorylated 
p53 in individual cells, indicating that the ability of a single phosphorylated ATM focus 
to phosphorylate p53 depends on focus growth (Fig. 3F). Furthermore, the treatment of 
an ATM specific inhibitor (KU55933) from 4 h after IR dramatically decreased p53 
phosphorylation to control levels, though the small foci of phosphorylated ATM 
persisted for over 24 h (Fig. 5E). These results clearly indicate that the small 
phosphorylated ATM foci are insufficient for p53 phosphorylation, supporting our 
notion that the function of a phosphorylated ATM focus depends on its size. 
Interestingly, the growth of the persistent foci was severely compromised in AT-, and 
NBS cells, though the initial foci growth was apparently normal in both cells (Fig. 4C, 
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4D, and Table 3). Previous studies reported that IR-induced G1 arrest is abolished in AT 
cells, and partially compromised in NBS cells [3, 4, 31, 32]. Of note, ≥1.6 µm foci of 
phosphorylated ATM or 53BP1 were rarely observed in both cells. These results 
indicate that ATM and NBS1 are important for the growth of the persistent foci, and 
imply the biological significance of the ≥1.6 µm foci. Our results can be one of the 
explanations why G1 checkpoint is not fully activated in NBS cells. Namely, in NBS 
cells, potential of phosphorylated ATM foci to phosphorylate p53 is lowered because of 
the defective foci growth. However, greater number of the “smaller “ persistent foci, 
which is a result of inefficient DSB repair, may partially supplement impaired foci 
growth, that may result in partial defect of G1 arrest in NBS cells. 
     It is highly likely that other DNA damage checkpoint factors are involved, not 
only in the initial foci growth, but also the growth of the persistent foci presented here 
(Fig. 1D). In fact, as shown in Fig. 1D, all of the grown foci of phosphorylated H2AX, 
MDC1, 53BP1 were colocalized with the grown phosphorylated ATM foci. Recent 
studies demonstrated that MDC1 is important for maintenance of H2AX 
phosphorylation and phosphorylated H2AX foci, rather than initial phosphorylation and 
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foci formation [38]. Furthermore, although MDC1 does not affect autophosphorylation 
of ATM, foci formation of phosphorylated ATM is completely abrogated in MDC1 (-/-) 
MEFs and severely compromised in MDC1-shRNA-expressing cells [38, 39]. These 
results indicate the importance of multi-factorial complex in amplifying DNA damage 
checkpoint signals.     
     Recently, it is proposed that multiple DSBs are assembled at a single or a few 
site(s) to be repaired [40, 41]. It can be assumed that a grown persistent focus represents 
such a “repair center”. However, distribution of foci diameter 48 h after IR was similar 
between 1–8 Gy (Fig. 1G). If the grown persistent foci consisted of many DSBs, size of 
the foci would become larger dose-dependently. Furthermore, recent studies 
demonstrated that DSB ends or DSB-containing chromatin in mammalian cells exhibits 
limited mobility [42, 43]. Therefore, we concluded that the grown persistent focus does 
not represent a repair center.           
     We propose that the growth of the persistent focus of checkpoint factors is the 
mechanism that amplifies a signal from a single chromosome aberration to the sufficient 
levels for G1 arrest. The results in the present study suggest the extreme sensitivity of 
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G1 arrest, because a single grown persistent focus can execute G1 arrest. Considering 
the persistence of G1 arrest, we believe that the “growth of persistent foci” is a universal 
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Figure 1. Growth of persistent IR-induced foci in normal human diploid cells. 
(A) Kinetics of phosphorylated ATM foci number after IR. HE49 cells were  
unirradiated (C) or irradiated with 1 Gy of X-rays, and then, fixed at indicated time 
points, followed by immunofluorescence staining for phosphorylated ATM (Ser1981). 
More than 100 cells were analyzed at each time point. The average number of foci per 
nucleus was calculated, and indicated above the bars in the graph. 
(B) Growth of the persistent phosphorylated ATM foci. HE49 cells were unirradiated 
(C) or irradiated with 1 Gy of X-rays and fixed at indicated time points, followed by 
immunofluorescence staining for phosphorylated ATM (Ser1981, red). Nucleus was 
counterstained with DAPI (blue). 
(C) Kinetics of foci size distribution of phosphorylated ATM after IR. HE49 cells were 
unirradiated (C) or irradiated with 1 Gy of X-rays and fixed at indicated time points, 
followed by immunofluorescence staining for phosphorylated ATM (Ser1981). 
Diameter of phosphorylated ATM foci was measured as described in Materials and 
Methods. Data were obtained from more than 100 foci positive cells at each time point. 
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(D) Growth of the persistent foci of other checkpoint factors. HE49 cells were irradiated 
with 1 Gy of X-rays and fixed 24 h later, followed by immunofluorescence staining for 
phosphorylated ATM (Ser1981, green) and phosphorylated histone H2AX (Ser139), 
MDC1, 53BP1, or NBS1 (red). Nucleus was counterstained with DAPI (blue). 
(E) Dose-dependency of the percentage of the large phosphorylated ATM foci positive  
cells. G0-synchronized HE49 cells were unirradiated or irradiated with 1, 2, 4, 6, or 8 
Gy of X-rays, then, replated onto coverslips and fixed 48 h later, followed by 
immunofluorescence staining for phosphorylated ATM (Ser1981). Foci of 1.6 µm or 
more in diameter were counted as the large foci. Focus diameter measurement was 
performed as described in Materials and Methods. Data were obtained from more than 
100 cells at each dose. 
(F) Dose-dependency of the average number of the large phosphorylated ATM foci per 
cell. Sample preparation and analysis were performed as described in (E). Data were 
obtained from more than 100 cells at each dose. 
(G) Distribution of foci size after different doses of X-rays. Sample preparation and 
analysis were performed as described in (E). Data were obtained from more than 100 
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foci positive cells at each dose. 
 
Figure. 2. Correlation between the growth of the persistent phosphorylated ATM foci 
and G1 arrest. 
(A) Percentage of cells with no focus, small focus (<1.6 µm), or large focus (≥1.6 µm) 
in RPA positive cells. G0-synchronized HE49 cells were unirradiated (control), or 
irradiated with 1 Gy of X-rays and then, immediately released from synchronization. 
Twenty-four hours after release, cells were fixed, followed by immunofluorescence 
staining for phosphorylated ATM (Ser1981) and RPA. RPA was stained to detect S 
phase cells. Most grown focus in each cell was analyzed, and focus diameter was 
measured as described in Materials and Methods. Average percentage from three 
independent experiments is shown. Data were obtained from more than 200 cells in 
each experiment.  
(B) Relative efficiency of S phase entry in cells with the small, or the large 
phosphorylated ATM foci. The same data as in (A) were used in this analysis. The 
percentage of RPA positive cells without a focus was set for 100%, and the relative 
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average percentage of RPA positive cells with the small (<1.6 µm) or the large (≥1.6 
µm) focus was indicated.  
(C) Percentage of cells with no focus, small focus (<1.6 µm), or large focus (≥1.6 µm)  
in BrdU positive cells. G0-synchronized HE49 cells were unirradiated (control), or 
irradiated with 1 Gy of X-rays and then, immediately released from synchronization. At 
the time of release, cells were replated into media containing 0.5 mM BrdU, and then, 
cells were incubated with the media until fixation. Twenty-four hours after release, cells 
were fixed, followed by immunofluorescence staining for phosphorylated ATM 
(Ser1981) and BrdU. Most grown focus in each cell was analyzed, and focus diameter 
was measured as described in Materials and Methods. Data were obtained from more 
than 200 cells. 
(D) Relative efficiency of S phase entry in cells with the small, or the large 
phosphorylated ATM foci. The same data as in (C) were used in this analysis. The 
percentage of BrdU positive cells without a focus was set for 100%, and the relative 
percentage of BrdU positive cells with the small (<1.6 µm) or the large (≥1.6 µm) focus 
was indicated.  
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Figure 3. Correlation between the growth of the persistent phosphorylated ATM foci and 
the level of p53 phosphorylation at Ser15.  
(A) Schematic representation of experimental procedures in Figure 3.  
(B) Immunofluorescence images of phosphorylated ATM foci and Ser15- 
phosphorylated p53 after IR. G0-synchronized HE49 cells or WG1799 cells pretreated 
with 8 µM Nutlin-3 were irradiated with 1 Gy of X-rays, then replated, and fixed at 
indicated time points, followed by immunofluorescence staining for phosphorylated 
ATM (Ser1981, green) and phosphorylated p53 (Ser15, red). Nucleus was 
counterstained with DAPI (blue). Note that the strong fluorescence intensity of 
Ser15-phosphorylated p53 is specifically observed in normal cells with grown 
phosphorylated ATM foci at 8, or 24 h after IR. 
(C) Correlation between nucleoplasmic fluorescence intensity of phosphorylated ATM  
and that of phosphorylated p53. Fluorescence intensity of both proteins was measured 
as described in Materials and Methods. Data were obtained from more than 100 cells at 
each time point.  
(D) p53 phosphorylation at Ser15 after 1 Gy of X-rays in normal and NBS cells. 
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G0-synchronized HE49 or WG1799 cells were pretreated with 32 µM Nutlin-3 for 24 h, 
followed by 1 Gy irradiation. Cells were harvested at indicated time points, and were 
subjected to western blotting for Ser15-phosphorylated p53, p53, and -tublin (loading 
control).  
(E) Induced level of p53 phosphorylation. Band intensity of Ser15-phosphorylated p53 
in (D) was measured using NIH image.  
(F) Correlation between diameter of a single phosphorylated ATM focus and 
fluorescence intensity of phosphorylated p53. G0-synchronized HE49 cells pretreated 
with 8 µM Nutlin-3 were irradiated with 1 Gy of X-rays, then replated, and fixed at 24 h 
after IR, followed by immunofluorescence staining for phosphorylated ATM (Ser1981) 
and phosphorylated p53 (Ser15). Focus diameter and fluorescence intensity were 
measured as described in Materials and Methods. Data were obtained from more than 
100 cells with a single phosphorylated ATM focus. 
 
Figure 4. Defective growth of the persistent 53BP1 foci in AT-, and NBS cells after IR. 
(A) Kinetics of 53BP1 foci number in AT, NBS, and normal cells after IR. AT2KY, 
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AT5BI, WG1799, and HE49 cells were unirradiated (0), or irradiated with 1 Gy of 
X-rays and fixed at indicated time points. After fixation, cells were stained for 53BP1. 
In the graph, average foci number calculated from more than 100 cells was plotted at 
each time point.  
(B) Number of 53BP1 foci in unirradiated AT, NBS, and normal cells. Each bar graph 
shows average foci number calculated from more than 100 cells. 
(C) Kinetics of foci size distribution of 53BP1 in AT, NBS, and normal cells after IR. 
AT2KY, AT5BI, WG1799, and HE49 cells were unirradiated (C) or irradiated with 1 Gy 
of X-rays, and fixed at indicated time points. After fixation, cells were stained for 
53BP1. Focus diameter measurement was performed as described in Materials and 
Methods. Data were obtained from more than 100 foci positive cells at each time point. 
(D) Immunofluorescence images of the persistent 53BP1 foci in AT, NBS, and normal 
cells after IR. AT2KY, AT5BI, WG1799, and HE49 cells were irradiated with 1 Gy of 
X-rays, and fixed 24 h later. After fixation, cells were stained for 53BP1 (green). 
Nucleus was counterstained with DAPI (blue). Cells with typical number and size of 
53BP1 foci are shown. 
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Figure 5. ATM-kinase-dependent foci growth and foci-size-dependent p53 
phosphorylation. 
(A) Schematic representation of experimental procedures. G0-synchronized HE49 cells  
were irradiated with 1 Gy of X-rays. From 4 h after IR to the time of fixation, 10 µM 
KU55933 was either treated or mock-treated. Twenty-four hours after IR, cells were 
fixed, followed by immunofluorescence staining for phosphorylated ATM (Ser1981). 
(B) Images of typical foci of phosphorylated ATM with or without KU treatment. 
(C) Mean foci diameter of phosphorylated ATM with or without KU treatment. Mean 
foci diameter was measured as described in Materials and Methods. The data were 
obtained from more than 50 foci in more than 50 nuclei.  
(D) Schematic representation of experimental procedures. G0-synchronized HE49 cells 
were pretreated with 8 µM Nutlin-3 for 24 h, then irradiated with 1 Gy of X-rays. From 
4 h after IR to the time of fixation, 10 µM KU55933 was either treated or mock-treated. 
Twenty-four hours after IR, cells were fixed, followed by immunofluorescence staining 
for phosphorylated ATM (Ser1981) and phosphorylated p53 (Ser15). 
(E) Images of typical phosphorylated ATM foci and phosphorylated p53. Control cells 
 48
(right panel) were treated only with 8 µM nutlin-3, and were not exposed to KU55933 
and X-rays. White arrows in left panel indicate cells positive for phosphorylation of p53 
at Ser15 with the large phosphorylated ATM foci in non-KU-treated irradiated cells, 
which were not found in KU-treated irradiated cells (middle) and control cells (right).  
 
Table 1. Kinetics of the percentage of cells with phosphorylated ATM foci or large 
phosphorylated ATM foci after IR. HE49 cells were unirradiated (C) or irradiated with 1 
Gy of X-rays and fixed at indicated time points. After fixation, immunofluorescence 
staining was performed for phosphorylated ATM (Ser1981). Foci of 1.6 µm or more in 
diameter were counted as the large foci. 
 
Table 2. Inhibition of cell cycle progression at G1/S by the large foci. G0-synchronized 
HE49 cells were unirradiated (control) or irradiated with 1 Gy of X-rays. Immediately 
after irradiation, cells were released from synchronization, and fixed 24 h after release, 
followed by immunofluorescence staining for phosphorylated ATM (Ser1981) and RPA 
or phosphorylated histone H3 (Ser10). In this table, total number of analyzed cells was 
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set for 100%. Percentage of S phase cells or G2/M cells was calculated by counting 
RPA positive cells or phosphorylated histone H3 positive cells, respectively. Percentage 
of G1 cells was calculated by subtracting the percentage of RPA, and phosphorylated 
H3 positive cells from the percentage of cells with each foci status. Data were obtained 
from more than 500 cells. 
 
Table 3. Relationship between focus size of phosphorylated ATM and G1/S progression 
in NBS and normal cells. G0-synchronized WG1799 or HE49 cells were unirradiated 
(control), or irradiated with 1 Gy of X-rays and then, immediately released from 
synchronization. Twenty-four hours after release, cells were fixed, followed by 
immunofluorescence staining for phosphorylated ATM (Ser1981) and RPA. Most grown 
focus in the nucleus was analyzed, and focus diameter was measured as described in 
Materials and Methods. Average percentage from three independent experiments is 
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